PMID: 11323286DOI: 10.1016/s1471-4906(01)01896-8Apr 27, 2001Paper
The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity
Trends in Immunology
R F Wang
Abstract
The identification of tumor antigens has generated a resurgence of interest in immunotherapy for cancer. However, both clinical and animal studies suggest that therapeutic strategies that have mainly focused on the use of CD8+ T cells (and MHC class I-restricted tumor antigens) are not effective in eliminating cancer cells. Recent interest has been directed towards the use of CD4+ T cells in generating antitumor immunity. To this end, the identification of MHC class II-restricted tumor antigens that can stimulate CD4+ T cells might provide opportunities for developing effective cancer vaccines.
References
Dec 13, 1991·Science·P van der BruggenT Boon
Dec 22, 1988·The New England Journal of Medicine·S A RosenbergC A Seipp
Dec 15, 1983·International Journal of Cancer. Journal International Du Cancer·M J MattesK O Lloyd
Nov 1, 1995·The Journal of Experimental Medicine·I HaraA N Houghton
Jan 1, 1995·Immunity·P A MonachH Schreiber
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·S SandersonN Shastri
Sep 1, 1995·Science·T WölfelD Beach
Feb 1, 1995·The Journal of Experimental Medicine·R F WangS A Rosenberg
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y KawakamiS A Rosenberg
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y KawakamiS A Rosenberg
Jan 28, 1994·Cell·R N Germain
Aug 1, 1993·The Journal of Experimental Medicine·V BrichardT Boon
Feb 23, 1996·Cell·P Cresswell
Mar 1, 1996·The Journal of Experimental Medicine·R F WangS A Rosenberg
Mar 1, 1996·The Journal of Experimental Medicine·P F RobbinsS A Rosenberg
May 1, 1996·The Journal of Experimental Medicine·S L TopalianP F Robbins
Sep 1, 1996·Scientific American·L J Old
Dec 1, 1996·The Journal of Experimental Medicine·R F WangS A Rosenberg
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Jun 1, 1997·Nature Medicine·I MeleroL Chen
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·J van BergenF Koning
Aug 29, 1997·The Journal of Experimental Medicine·S MandruzzatoP van der Bruggen
Feb 7, 1998·The Journal of Experimental Medicine·E JägerA Knuth
Mar 28, 1998·The Journal of Experimental Medicine·F OssendorpC J Melief
Mar 11, 1998·Current Opinion in Immunology·A O'GarraK Gijbels
Mar 21, 1998·Nature Medicine·S A RosenbergD E White
Mar 21, 1998·Nature Medicine·F O NestleD Schadendorf
Mar 25, 1998·Immunogenetics·H KobayashiM Katagiri
May 23, 1998·The Journal of Experimental Medicine·E StockertL J Old
Aug 15, 1998·Critical Reviews in Immunology·P A Morel, T B Oriss
Aug 26, 1998·Current Biology : CB·P L Felgner
Sep 2, 1998·Current Opinion in Immunology·A J ZajacR Ahmed
Sep 22, 1998·The Journal of Experimental Medicine·G S OggV Cerundolo
Oct 2, 1998·Cancer Immunology, Immunotherapy : CII·K LiG Pawelec
Oct 3, 1998·Human Immunology·S FujiiY Nishimura
Oct 24, 1998·Critical Reviews in Immunology·W C Lai, M Bennett
Oct 31, 1998·Current Opinion in Immunology·D M Pardoll, S L Topalian
Dec 22, 1998·The Journal of Experimental Medicine·S A Kalams, B D Walker
Dec 22, 1998·The Journal of Experimental Medicine·K HungH Levitsky
Mar 2, 1999·The Journal of Experimental Medicine·R E ToesC J Melief
Mar 2, 1999·The Journal of Experimental Medicine·R PieperS L Topalian
Mar 2, 1999·The Journal of Experimental Medicine·P ChauxP van der Bruggen
Mar 2, 1999·The Journal of Experimental Medicine·S ManiciM P Protti
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·W W OverwijkN P Restifo
Apr 16, 1999·Immunity·S A Rosenberg
May 20, 1999·The Journal of Experimental Medicine·R F WangS A Rosenberg
May 21, 1999·Science·R F WangS A Rosenberg
CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·D MumbergH Schreiber
Oct 8, 1999·Immunity·E Gilboa
Nov 5, 1999·Immunity·P ShrikantM F Mescher
❮ Previous
Next ❯
Citations
Aug 4, 2010·Archivum Immunologiae Et Therapiae Experimentalis·Akshata Udyavar, Terrence L Geiger
Sep 28, 2004·Cancer Immunology, Immunotherapy : CII·José Manuel RojasRobert C Rees
Mar 8, 2005·Cancer Immunology, Immunotherapy : CII·Zheng-Cai JiaYu-Zhang Wu
Jul 22, 2005·Cancer Immunology, Immunotherapy : CII·Jana BabatzMartin Bornhäuser
Mar 24, 2006·Cancer Immunology, Immunotherapy : CII·Deepak P AssudaniRobert C Rees
Jul 10, 2007·Cancer Immunology, Immunotherapy : CII·Wei LiZi-Hai Li
Feb 3, 2009·Cancer Immunology, Immunotherapy : CII·Kazuaki ChikamatsuKeisuke Masuyama
Mar 1, 2012·Cancer Immunology, Immunotherapy : CII·Jing ZhangXiubao Ren
Jul 27, 2007·Breast Cancer Research and Treatment·Carsten T ViehlPeter S Goedegebuure
Mar 30, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Roberto Mallone, Gerald T Nepom
Mar 19, 2004·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A A AliC S McArdle
May 27, 2004·Vaccine·Aleksandra LenarczykAndreas Suhrbier
Jun 8, 2002·Journal of Molecular Biology·Eric J SundbergRoy A Mariuzza
Dec 4, 2003·Biochimica Et Biophysica Acta·Simone MocellinFrancesco M Marincola
Aug 6, 2003·Current Opinion in Immunology·Alessandro Sette, John Fikes
Aug 9, 2001·Trends in Immunology·G PawelecW Wagner
Feb 14, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Marcela V MausCarl H June
Feb 3, 2005·Nature Reviews. Microbiology·Rosemary RochfordAnn M Moormann
May 15, 2007·Leukemia·C StraubeM Schmitz
Jan 8, 2008·Oncogene·R-F WangH Y Wang
Oct 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yoshihiro MiyaharaRong-Fu Wang
Nov 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·H NishikawaH Shiku
May 22, 2002·The Journal of Experimental Medicine·Beatrice Schuler-ThurnerGerold Schuler
Jun 5, 2002·The Journal of Experimental Medicine·Helen Y WangRong-Fu Wang
Feb 11, 2004·The Journal of Experimental Medicine·Kui Shin VooRong-Fu Wang
Mar 9, 2005·The Journal of Experimental Medicine·Ping YuYang-Xin Fu
Feb 17, 2010·The Journal of Experimental Medicine·Ying XiePaul Andrew Antony
Jun 14, 2003·Human Gene Therapy·Gilda G HillmanJeffrey D Forman
Sep 21, 2004·Journal of Gastroenterology and Hepatology·Sun-Lung Tsai
Dec 25, 2003·Journal of Virology·G S TaylorA B Rickinson
Dec 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael J CallahanSamuel C Mok
Jan 4, 2005·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mikiko FukuiYuji Hinoda
Mar 6, 2007·Neuroimmunomodulation·Saleh Mohaghegh HazratiArmin Rashidi
Jun 5, 2002·The Journal of Clinical Investigation·Helen Y WangRong-Fu Wang
Apr 16, 2004·The Journal of Clinical Investigation·Maha AyyoubDanila Valmori
May 4, 2007·The Journal of Clinical Investigation·Eli Gilboa
Feb 24, 2012·PloS One·Olivier MoralèsNadira Delhem
Aug 10, 2012·Haematologica·Caroline PoliDanila Valmori
Nov 16, 2010·Clinical & Developmental Immunology·Hanka JähnischMarc Schmitz
Aug 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hiroyoshi NishikawaHiroshi Shiku
Feb 18, 2011·EMBO Molecular Medicine·Nele FestjensNico Callewaert
Mar 9, 2012·Clinical & Developmental Immunology·Trudy StraetemansReno Debets
May 15, 2010·Journal of Biomedicine & Biotechnology·Marc CartellieriMarc Schmitz
Nov 26, 2002·Immunological Reviews·Rong-Fu Wang
Mar 12, 2009·Cancer Research·Michael R ShurinValerian E Kagan
Apr 25, 2014·Expert Review of Vaccines·Laetitia CiccheleroNiek N Sanders
Aug 29, 2003·Expert Opinion on Biological Therapy·John D Fikes, Alessandro Sette
Dec 19, 2003·Expert Opinion on Biological Therapy·Graham S Taylor
Aug 27, 2005·Expert Opinion on Biological Therapy·Gavin M BendleHans J Stauss
Nov 26, 2003·International Journal of Cancer. Journal International Du Cancer·Hanno EhlkenStefan Eichmüller
❮ Previous
Next ❯
Related Concepts
Related Feeds
Cancer Vaccines
Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.
Related Papers
The Journal of Experimental Medicine
R E ToesC J Melief
Current Opinion in Immunology
D Pardoll, S L Topalian
Journal of Immunotherapy
Gang Zeng
Proceedings of the National Academy of Sciences of the United States of America
G ZengR F Wang
The Journal of Experimental Medicine
R F WangS A Rosenberg